Showing results (1701-1710 of 2,035) with videos related to

Sort By:
Pageof 204
British Journal of Haematology|December 21, 2012
MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophagesEllen Hebron, Chelsea Hope, Jaehyup Kim, et al.
Journal of Neurosurgery|February 5, 2008
A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigationBrian T Ragel, Isaac L Elam, David L Gillespie, et al.
Acta Physiologica (Oxford, England)|October 3, 2020
Natriuretic peptides relax human intrarenal arteries through natriuretic peptide receptor type-A recapitulated by soluble guanylyl cyclase agonistsAndreas Frees, Kasper B Assersen, Mia Jensen, et al.
American Journal of Physiology. Renal Physiology|June 6, 2019
Effect of spironolactone for 1 yr on endothelial function and vascular inflammation biomarkers in renal transplant recipientsLine A Mortensen, Claus Bistrup, Jane Stubbe, et al.
The Journal of Heredity|May 21, 2026
Evolving conservation: The role of unconventional approaches to restore contemporary vertebrate populations and genomic biodiversityBridgett M von Holdt, Matt James, Stephen J Gaughran, et al.
Journal of Neuro-Oncology|March 19, 2026
Lower-grade glioma imaging volumes and survival: a single-institution analysis of 90 patients after resection using intraoperative MRIJeffrey L Nadel, Nicholas T Gamboa, David Botros, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|September 1, 1990
Parenteral infusion of long- and medium-chain triglycerides and reticuloendothelial system function in manG L Jensen, E A Mascioli, D L Seidner, et al.
Journal of Hypertension|November 29, 2021
The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-γ and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertensionSai Sindhu Thangaraj, Christina Stolzenburg Oxlund, Micaella Pereira Da Fonseca, et al.
Pageof 204